Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-19)Premium Content

Five Prime Therapeutics Inc (FPRX)

2014-12-05@21:00:27 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-12-05@02:39:23 ET
Five Prime Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference (PMZ)

2014-12-04@21:00:09 ET
Five Prime Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-12-04@19:03:08 ET
8-K: FIVE PRIME THERAPEUTICS INC (EDK)

2014-12-04@16:05:27 ET
Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Trial Evaluating FPA144 in Gastric Cancer (PMZ)

2014-12-03@11:22:13 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-12-03@09:16:31 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-12-03@06:49:01 ET
Form 4: Update Filing for Five Prime Therapeutics Inc (FPRX) (VKR)

2014-12-02@07:01:17 ET
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014 (MTO)

2014-11-28@09:30:00 ET
The Zacks Analyst Blog Highlights:BioMarin, Prosensa, Five Prime Therapeutics, AbbVie, Amgen, Biogen and Vertex (PRN)

2014-11-25@16:11:22 ET
Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference (PMZ)

2014-11-24@13:58:08 ET
Monday Sector Leaders: Music & Electronics Stores, Drugs (MNV)

2014-11-24@09:52:25 ET
8-K: FIVE PRIME THERAPEUTICS INC (EDK)

2014-11-24@08:59:09 ET
Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types (PMZ)

2014-11-24@08:59:01 ET
Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types (BIZ)

2014-11-18@14:37:08 ET
8-K: FIVE PRIME THERAPEUTICS INC (EDK)

2014-11-17@16:50:43 ET
Five Prime Therapeutics Initiates Dosing of Rheumatoid Arthritis Patients in Its Phase 1 Clinical Trial of FPA008 (PMZ)

2014-11-13@16:08:56 ET
Five Prime Therapeutics to Present Data From Healthy Volunteer Cohorts in Phase 1 Trial of FPA008 at the 2014 ACR/ARHP Annual Scientific Meeting (PMZ)

2014-11-12@07:33:08 ET
10-Q: FIVE PRIME THERAPEUTICS INC (EDG)